Company: TVRD
Filing Date: 2025-02-14
Form Type: 424B3
Source: 0001104659-25-014310
Chunk: 677

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-02-14
Form: 424B3
Chunk 677
---
 more than 5% of any class of its common stock, or any member of the immediate family of any of the foregoing persons, in which the amount involved exceeds $120,000 (or, if less, 1% of the average of its total assets in a fiscal year) and such person would have a direct or indirect interest, must be presented to its board of directors or its audit committee for review, consideration and approval. In approving or rejecting any such proposal, its board of directors or its audit committee is to consider the material facts of the transaction, including whether the transaction is on terms no less favorable than terms generally available to an unaffiliated third party under the same or similar circumstances and the extent of the related person’s interest in the transaction.

<div align='center'>389</div>

TABLE OF CONTENTS

### DESCRIPTION OF CARA CAPITAL STOCK
As of the date of this proxy statement/prospectus, Cara’s amended and restated certificate of incorporation authorizes Cara to issue 16,666,667 shares of common stock, par value $0.001 per share, and 5,000,000 shares of preferred stock, par value $0.001 per share. As of December 31, 2024, 4,571,229 shares of common stock were outstanding and no shares of preferred stock were outstanding.

The following summary description of Cara’s capital stock is based on the provisions of Cara’s amended and restated certificate of incorporation as well as Cara’s amended and restated bylaws, and the applicable provisions of the DGCL. This information is qualified entirely by reference to the applicable provisions of Cara’s amended and restated certificate of incorporation, amended and restated bylaws and the DGCL. For information on how to obtain copies of Cara’s amended and restated certificate of incorporation and amended and restated bylaws, which are exhibits to the registration statement of which this prospectus is a part, see “Where You Can Find Additional Information.”

#### Common Stock
The holders of Cara’s common stock are entitled to one vote for each share held of record on all matters submitted to a vote of stockholders. The holders of Cara’s common stock do not have cumulative voting rights in the election of directors. Subject to preferences that may be applicable to any outstanding shares of preferred stock, the holders of common stock are entitled to receive ratably such dividends as may be declared by Cara’s board of directors out of legally available funds. Upon Cara’s liquidation, dissolution or winding up, holders of